Arkolith/Insider Trading/PMVP/Form 4

Mack David Henry

President and CEO, DirectorPMV Pharmaceuticals, Inc. (PMVP) · full profile →Form 4 · filed Nov 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 10, 2023Gift(G)85K—$0279K
Nov 10, 2023Gift(G)85K—$0165K
Oct 18, 2023Option exercise(M)198K$0.53$105K364K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 7, 2023Option exercise(M)198K—$0109K

Transaction Codes

G
Gift
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-054997) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for PMV Pharmaceuticals, Inc.

Build

Ask your agent about PMVP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001209191-23-054997"
Ask your agent
Use Arkolith to summarize insider buying and selling at PMV Pharmaceuticals, Inc.
over the last 90 days and cite the filings.